🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Sjögren's syndrome (pSS) is a common chronic auto-immune disease, c...
Status
Completed
Location
University Medical Center Groningen
Start Date
2014-08
Trial ID
NCT02067910
Treatments Being Tested
Background: CTLA4 stands for cytotoxic T-lymphocyte antigen-4. It is a pro...
Status
Withdrawn
Location
National Institutes of Health Clinical Center
Start Date
2023-11-30
Trial ID
NCT03733067
Short Term: The purpose of this clinical research study is to learn if abat...
Status
Completed
Location
Local Institution
Start Date
2002-12
Trial ID
NCT00048568
Treatments Being Tested
The purpose of this study is to demonstrate that Abatacept combined with Me...
Status
Completed
Location
Local Institution
Start Date
2006-06
Trial ID
NCT00345748
There is no standard of care therapy for patients with granulomatous-lympho...
Status
Recruiting
Location
University of California, San Francisco
Start Date
2021-07-14
Trial ID
NCT04925375
The objective of the study is to assess the single dose PK, safety, tolerab...
Status
Unknown
Location
Multiple Locations
Start Date
2016-10
Trial ID
NCT02805010
The purpose of this study is to compare the clinical efficacy including joi...
Status
Completed
Location
Local Institution
Start Date
2013-04-11
Trial ID
NCT01758198
Treatments Being Tested
Trial to Evaluate the Efficacy and Safety of Abatacept subcutaneous (SC) in...
Status
Completed
Location
Local Institution - 0015
Start Date
2017-05-04
Trial ID
NCT02971683
Treatments Being Tested
The purpose of this clinical research study is to determine whether abatace...
Status
Completed
Location
Local Institution
Start Date
2002-12
Trial ID
NCT00048581
The purpose of this clinical research study is to learn if abatacept is saf...
Status
Completed
Location
Local Institution
Start Date
2002-12
Trial ID
NCT00048932
Treatments Being Tested